Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment

Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment

Abstract Hypothyroidism is a risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD) but it is not clear whether subclinical hypothyroidism (SCH) increases the risk of MASLD and whether SCH patients with MASLD require treatment. In this study, we reviewed articles published...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Sicheng Pu, Binbin Zhao, Yuxuan Jiang, Xuejiao Cui
Format: Artykuł
Język:English
Wydane: BMC 2025-02-01
Seria:Lipids in Health and Disease
Hasła przedmiotowe:
Hypothyroidism
Subclinical hypothyroidism
Non-alcoholic fatty liver disease
Metabolic dysfunction-associated steatotic liver disease
Molecular roles
Thyroid-related medication
Dostęp online:https://doi.org/10.1186/s12944-025-02474-0

Internet

https://doi.org/10.1186/s12944-025-02474-0

Podobne zapisy